Cargando…

Hepatocyte nuclear factor 1 beta: A perspective in cancer

Hepatocyte nuclear factor 1 beta (HNF1 β/B) exists as a homeobox transcription factor having a vital role in the embryonic development of organs mainly liver, kidney and pancreas. Initially described as a gene causing maturity‐onset diabetes of the young (MODY), HNF1β expression deregulation and sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, Shubhra, Srinivasan, Srilakshmi, Batra, Jyotsna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940219/
https://www.ncbi.nlm.nih.gov/pubmed/33580750
http://dx.doi.org/10.1002/cam4.3676
_version_ 1783661905736368128
author Chandra, Shubhra
Srinivasan, Srilakshmi
Batra, Jyotsna
author_facet Chandra, Shubhra
Srinivasan, Srilakshmi
Batra, Jyotsna
author_sort Chandra, Shubhra
collection PubMed
description Hepatocyte nuclear factor 1 beta (HNF1 β/B) exists as a homeobox transcription factor having a vital role in the embryonic development of organs mainly liver, kidney and pancreas. Initially described as a gene causing maturity‐onset diabetes of the young (MODY), HNF1β expression deregulation and single nucleotide polymorphisms in HNF1β have now been associated with several tumours including endometrial, prostate, ovarian, hepatocellular, renal and colorectal cancers. Its function has been studied either as homodimer or heterodimer with HNF1α. In this review, the role of HNF1B in different cancers will be discussed along with the role of its splice variants, and its emerging role as a potential biomarker in cancer.
format Online
Article
Text
id pubmed-7940219
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-79402192021-03-16 Hepatocyte nuclear factor 1 beta: A perspective in cancer Chandra, Shubhra Srinivasan, Srilakshmi Batra, Jyotsna Cancer Med Cancer Biology Hepatocyte nuclear factor 1 beta (HNF1 β/B) exists as a homeobox transcription factor having a vital role in the embryonic development of organs mainly liver, kidney and pancreas. Initially described as a gene causing maturity‐onset diabetes of the young (MODY), HNF1β expression deregulation and single nucleotide polymorphisms in HNF1β have now been associated with several tumours including endometrial, prostate, ovarian, hepatocellular, renal and colorectal cancers. Its function has been studied either as homodimer or heterodimer with HNF1α. In this review, the role of HNF1B in different cancers will be discussed along with the role of its splice variants, and its emerging role as a potential biomarker in cancer. John Wiley and Sons Inc. 2021-02-13 /pmc/articles/PMC7940219/ /pubmed/33580750 http://dx.doi.org/10.1002/cam4.3676 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Cancer Biology
Chandra, Shubhra
Srinivasan, Srilakshmi
Batra, Jyotsna
Hepatocyte nuclear factor 1 beta: A perspective in cancer
title Hepatocyte nuclear factor 1 beta: A perspective in cancer
title_full Hepatocyte nuclear factor 1 beta: A perspective in cancer
title_fullStr Hepatocyte nuclear factor 1 beta: A perspective in cancer
title_full_unstemmed Hepatocyte nuclear factor 1 beta: A perspective in cancer
title_short Hepatocyte nuclear factor 1 beta: A perspective in cancer
title_sort hepatocyte nuclear factor 1 beta: a perspective in cancer
topic Cancer Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940219/
https://www.ncbi.nlm.nih.gov/pubmed/33580750
http://dx.doi.org/10.1002/cam4.3676
work_keys_str_mv AT chandrashubhra hepatocytenuclearfactor1betaaperspectiveincancer
AT srinivasansrilakshmi hepatocytenuclearfactor1betaaperspectiveincancer
AT batrajyotsna hepatocytenuclearfactor1betaaperspectiveincancer